{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:56:52Z","timestamp":1759334212535,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02722-3","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:38:48Z","timestamp":1759235928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cotrimoxazole use is associated with lower total and non-high density lipoprotein cholesterol among people with HIV: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Joseph Baruch","family":"Baluku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Nabwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Olum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Patrick","family":"Akabwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"2722_CR1","unstructured":"UNAIDS. The urgency of now: AIDS at a crossroads. 2024. Available at: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update_en.pdf."},{"key":"2722_CR2","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","volume":"3","author":"JL Marcus","year":"2020","unstructured":"Marcus JL, Leyden WA, Alexeeff SE, Anderson AN, Hechter RC, Hu H, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000\u20132016. JAMA Netw Open. 2020;3:e207954. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.7954.","journal-title":"JAMA Netw Open"},{"key":"2722_CR3","doi-asserted-by":"publisher","first-page":"e1001418","DOI":"10.1371\/journal.pmed.1001418","volume":"10","author":"LF Johnson","year":"2013","unstructured":"Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013;10:e1001418. https:\/\/doi.org\/10.1371\/journal.pmed.1001418.","journal-title":"PLoS Med"},{"key":"2722_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/0956462416632428","volume":"28","author":"M Farahani","year":"2017","unstructured":"Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28:636\u201350. https:\/\/doi.org\/10.1177\/0956462416632428.","journal-title":"Int J STD AIDS"},{"key":"2722_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12879-021-06962-3","volume":"22","author":"GJ Mollel","year":"2022","unstructured":"Mollel GJ, Moshi L, Hazem H, Eichenberger A, Kitau O, Mapesi H, et al. Causes of death and associated factors over a decade of follow-up in a cohort of people living with HIV in rural Tanzania. BMC Infect Dis. 2022;22:37. https:\/\/doi.org\/10.1186\/s12879-021-06962-3.","journal-title":"BMC Infect Dis"},{"key":"2722_CR6","doi-asserted-by":"publisher","first-page":"e00098","DOI":"10.1128\/cmr.00098-22","volume":"37","author":"I Nazari","year":"2024","unstructured":"Nazari I, Feinstein MJ. Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management. Clin Microbiol Rev. 2024;37:e00098\u201322. https:\/\/doi.org\/10.1128\/cmr.00098-22.","journal-title":"Clin Microbiol Rev"},{"key":"2722_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","volume":"389","author":"SK Grinspoon","year":"2023","unstructured":"Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, et al. Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med. 2023;389:687\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2304146.","journal-title":"N Engl J Med"},{"key":"2722_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(14)71011-4","volume":"15","author":"JA Church","year":"2015","unstructured":"Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis. 2015;15:327\u201339. https:\/\/doi.org\/10.1016\/S1473-3099(14)71011-4.","journal-title":"Lancet Infect Dis"},{"key":"2722_CR9","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","volume":"2","author":"AB Suthar","year":"2015","unstructured":"Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, et al. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis. Lancet HIV. 2015;2:e137\u2013150. https:\/\/doi.org\/10.1016\/S2352-3018(15)00005-3.","journal-title":"Lancet HIV"},{"key":"2722_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav0537","volume":"11","author":"CD Bourke","year":"2019","unstructured":"Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, et al. Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. Sci Transl Med. 2019;11:eaav0537. https:\/\/doi.org\/10.1126\/scitranslmed.aav0537.","journal-title":"Sci Transl Med"},{"key":"2722_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiz495","volume":"222","author":"CD Bourke","year":"2020","unstructured":"Bourke CD, Prendergast AJ. The anti-inflammatory effects of cotrimoxazole prophylaxis for people living with human immunodeficiency virus in sub-Saharan Africa. J Infect Dis. 2020;222:347\u201350. https:\/\/doi.org\/10.1093\/infdis\/jiz495.","journal-title":"J Infect Dis"},{"key":"2722_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1097\/QAD.0b013e32834be088","volume":"25","author":"JV Baker","year":"2011","unstructured":"Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, et al. Inflammation predicts changes in high-density lipoprotein particles and Apolipoprotein A1 following initiation of antiretroviral therapy. AIDS. 2011;25:2133\u201342. https:\/\/doi.org\/10.1097\/QAD.0b013e32834be088.","journal-title":"AIDS"},{"key":"2722_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","volume":"119","author":"FC McGillicuddy","year":"2009","unstructured":"McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation. 2009;119:1135\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.810721.","journal-title":"Circulation"},{"key":"2722_CR14","first-page":"152","volume":"30","author":"KV Pugalendhi","year":"1992","unstructured":"Pugalendhi KV, Sudhakaran PR, Ramakrishnan S. Effect of antimicrobials on cholesterol synthesis and content in liver and small intestines. Indian J Exp Biol. 1992;30:152\u20134.","journal-title":"Indian J Exp Biol"},{"key":"2722_CR15","first-page":"141","volume":"33","author":"KV Pugalendi","year":"1996","unstructured":"Pugalendi KV, Ramakrishnan S, Padmanabhan P. Effect of cotrimoxazole (Bactrim) on cholesterol metabolism. Indian J Biochem Biophys. 1996;33:141\u20134.","journal-title":"Indian J Biochem Biophys"},{"key":"2722_CR16","first-page":"33","volume":"11","author":"M Mokhtari","year":"2009","unstructured":"Mokhtari M, Salehi S, Moghadamnya D. Effect of cotrimoxazole on biochemical blood factors in adult male rats. Yafteh. 2009;11:33\u201342.","journal-title":"Yafteh"},{"key":"2722_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cpt.2932","volume":"114","author":"B Vora","year":"2023","unstructured":"Vora B, Wen A, Yee SW, Trinh K, Azimi M, Green EAE, et al. The effect of Trimethoprim on thiamine absorption: a transporter-mediated drug-nutrient interaction. Clin Pharmacol Ther. 2023;114:381\u201392. https:\/\/doi.org\/10.1002\/cpt.2932.","journal-title":"Clin Pharmacol Ther"},{"key":"2722_CR18","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1097\/MJT.0000000000000372","volume":"23","author":"K Meidahl Petersen","year":"2016","unstructured":"Meidahl Petersen K, Eplov K, Kj\u00e6r Nielsen T, Jimenez-Solem E, Petersen M, Broedbaek K, et al. The effect of Trimethoprim on serum folate levels in humans: A randomized, Double-Blind, Placebo-Controlled trial. Am J Ther. 2016;23:e382\u2013387. https:\/\/doi.org\/10.1097\/MJT.0000000000000372.","journal-title":"Am J Ther"},{"key":"2722_CR19","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. World Health Organization; 2021. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240031593."},{"key":"2722_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2025.100523","volume":"39","author":"JB Baluku","year":"2025","unstructured":"Baluku JB, Karungi D, Namanda B, Namiiro S, Katusabe S, Madalen AM, et al. Association of prior tuberculosis with altered cardiometabolic profiles of people with HIV: a comparative cross-sectional study in Uganda. J Clin Tuberc Other Mycobact Dis. 2025;39:100523. https:\/\/doi.org\/10.1016\/j.jctube.2025.100523.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2722_CR21","unstructured":"Ministry of Health. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda 2020. Available at: https:\/\/elearning.idi.co.ug\/wp-content\/uploads\/2022\/05\/Consolidated-Guidelines-for-the-Prevention-and-Treatment-of-HIV-and-AIDS-in-Uganda-2020.pdf."},{"key":"2722_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1001\/jama.2008.570","volume":"300","author":"CP O\u2019Brien","year":"2008","unstructured":"O\u2019Brien CP. The CAGE questionnaire for detection of alcoholism. JAMA. 2008;300:2054\u20136. https:\/\/doi.org\/10.1001\/jama.2008.570.","journal-title":"JAMA"},{"key":"2722_CR23","unstructured":"WHO clinical staging of HIV disease in adults, adolescents and children. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. World Health Organization; 2016. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK374293\/."},{"key":"2722_CR24","volume-title":"Prevention of cardiovascular disease. Pocket guidelines for assessment and management of cardiovascular risk","author":"World Health Organization","year":"2007","unstructured":"World Health Organization. Prevention of cardiovascular disease. Pocket guidelines for assessment and management of cardiovascular risk. Africa: Who\/Ish Cardiovascular Risk Prediction Charts for the African Region. World Health Organization; 2007."},{"key":"2722_CR25","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/eurjpc\/zwae119","volume":"31","author":"MK Hansen","year":"2024","unstructured":"Hansen MK, Mortensen MB, Olesen KKW, Thrane PG, Thomsen RW, Maeng M. Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: the Western Denmark heart registry. Eur J Prev Cardiol. 2024;31:1238\u201348. https:\/\/doi.org\/10.1093\/eurjpc\/zwae119.","journal-title":"Eur J Prev Cardiol"},{"key":"2722_CR26","first-page":"240","volume":"29","author":"S Niroumand","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic index of plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.","journal-title":"Med J Islam Repub Iran"},{"key":"2722_CR27","first-page":"282","volume":"33","author":"SMT Islam","year":"2022","unstructured":"Islam SMT, Osa-Andrews B, Jones PM, Muthukumar AR, Hashim I, Cao J. Methods of low-density lipoprotein-cholesterol measurement: analytical and clinical applications. EJIFCC. 2022;33:282\u201394.","journal-title":"EJIFCC"},{"key":"2722_CR28","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142019. Diabetes Care. 2019;42:S13\u201328.","journal-title":"Diabetes Care"},{"key":"2722_CR29","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA). J Hypertens. 2023;41:1874. https:\/\/doi.org\/10.1097\/HJH.0000000000003480.","journal-title":"J Hypertens"},{"key":"2722_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/ajcn\/nqy049","volume":"107","author":"RA Beraldo","year":"2018","unstructured":"Beraldo RA, Meliscki GC, Silva BR, Navarro AM, Bollela VR, Schmidt A, et al. Anthropometric measures of central adiposity are highly concordant with predictors of cardiovascular disease risk in HIV patients. Am J Clin Nutr. 2018;107:883\u201393. https:\/\/doi.org\/10.1093\/ajcn\/nqy049.","journal-title":"Am J Clin Nutr"},{"key":"2722_CR31","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1161\/01.ATV.17.12.3527","volume":"17","author":"G Fager","year":"1997","unstructured":"Fager G, Wiklund O. Cholesterol Reduction and Clinical Benefit. Arterioscler Thromb Vasc Biol. 1997;17:3527\u201333. https:\/\/doi.org\/10.1161\/01.ATV.17.12.3527.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2722_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","volume":"316","author":"MG Silverman","year":"2016","unstructured":"Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA. 2016;316:1289\u201397. https:\/\/doi.org\/10.1001\/jama.2016.13985.","journal-title":"JAMA"},{"key":"2722_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.clinthera.2007.05.012","volume":"29","author":"AL Gould","year":"2007","unstructured":"Gould AL, Davies GM, Alemao E, Yin DD, Cook JR. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther. 2007;29:778\u201394. https:\/\/doi.org\/10.1016\/j.clinthera.2007.05.012.","journal-title":"Clin Ther"},{"key":"2722_CR34","doi-asserted-by":"publisher","first-page":"117312","DOI":"10.1016\/j.atherosclerosis.2023.117312","volume":"383","author":"V Raja","year":"2023","unstructured":"Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, et al. Non-HDL-cholesterol in dyslipidemia: review of the state-of-the-art literature and outlook. Atherosclerosis. 2023;383:117312. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117312.","journal-title":"Atherosclerosis"},{"key":"2722_CR35","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with the human immunodeficiency virus: A systematic review and Meta-Analysis. Circulation. 2018;138:1100\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.033369.","journal-title":"Circulation"},{"key":"2722_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jacc.2023.04.050","volume":"82","author":"DK Kalra","year":"2023","unstructured":"Kalra DK, Vorla M, Michos ED, Agarwala A, Virani S, Duell PB, et al. Dyslipidemia in human immunodeficiency virus disease: JACC review topic of the week. J Am Coll Cardiol. 2023;82:171\u201381. https:\/\/doi.org\/10.1016\/j.jacc.2023.04.050.","journal-title":"J Am Coll Cardiol"},{"key":"2722_CR37","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S283402","author":"TS Yazie","year":"2020","unstructured":"Yazie TS. Dyslipidemia and associated factors in tenofovir disoproxil fumarate-based regimen among human immunodeficiency virus-infected Ethiopian patients: a hospital-based observational prospective cohort study. Drug Healthc Patient Saf. 2020. https:\/\/doi.org\/10.2147\/DHPS.S283402.","journal-title":"Drug Healthc Patient Saf"},{"key":"2722_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113889","volume":"242","author":"L Kong","year":"2022","unstructured":"Kong L, Yu S, Gu L, Geng M, Zhang D, Cao H, et al. Associations of typical antibiotic residues with elderly blood lipids and dyslipidemia in West Anhui, China. Ecotoxicol Environ Saf. 2022;242:113889. https:\/\/doi.org\/10.1016\/j.ecoenv.2022.113889.","journal-title":"Ecotoxicol Environ Saf"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02722-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:38:57Z","timestamp":1759235937000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02722-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2722"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02722-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were conducted in accordance with the Declaration of Helsinki. The study was approved by the Mildmay Uganda Research Ethics Committee (MUREC-2023-240), and the Uganda National Council of Science and Technology (HS2991ES) prior to participant recruitment. Study participants in the primary study provided written informed consent before study procedures were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}